reason report
margin expans top line growth rais ep cfo
bottom line reiter op rate post convo cfo
tom tran head ir ryan kubota rais estim
pt ep post huge ep initi
guidanc beat margin miss revenu hix growth came
expect ep goe conserv
expect prior year favor develop least
partial recur despit guidanc rang
low hang fruit margin expans larg end view
though see attract net margin profil rang
sustain harvest medic cost structur admin save
opportun highlight jan competitor confer off-set
deliber pressur design grow hix marketplac start
cost geograph in-market market expans neg
trend yield spread medicaid model growth top
line across mid-singl digit ss growth medicaid growth hix
modest opportun medicare/du ep goe
potenti bull case new contract
tx region expand anticip june contract award
balanc sheet strong debt cap ratio
parent cash mn debt pay day claim
payabl day next big catalyst report
expect rais may nyc day expect
color path growth across top line margin balanc
huge ep beat margin tax rate consensu
revenu huge ep beat across board
margin metric sg ratio tax rate servic revenu ratio
also beat beat particularli pronounc fl il tx
miss nm wa day claim payabl flat qoq
day yoy exhibit
initi guid beat ep includ prior
year develop miss revenu ep outlook larg
aid tax rate project street
hix marketplac perform guidanc surpris
downsid manag see revenu contract like
revers margin compress
today high singl digit drive membership gain expect hix
top line growth like suffici off-set margin
net debt total capit
price-to-earnings lt ep growth
average ep
estimate lt ep growth compound-annual-growth-rate ex
year price history/av daili volume mil
compani inform svb leerink llc research
revenu billion ep estim ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
rais ep magnitud guidanc also
includ recur prior year develop compar
see top line growth flattish
margin even ss growth offer mid-singl digit growth
growth hix repres balanc ep goe
potenti bull case new contract
tx region expand anticip june contract award
rais ep
balanc sheet strong debt cap ratio
parent cash mn debt pay exhibit
polici downsid headlin could creat volatil
view close half earn stream
across medicaid expans hix tx lawsuit decis
walk back scotu given american enjoy
coverag entitl fifth circuit court appeal
conserv southern court like hear case juli
rais pt modestli pt base price-to-earnings
averag ep see price-to-earnings
potenti expand pend court hear may day
potenti offer confid investor top line
growth stori margin preserv exhibit
reiter op rate post convo cfo tom tran head ir ryan
kubota rais estim pt ep post huge ep
initi guidanc beat margin miss revenu hix growth came
expect ep goe conserv expect prior year
favor develop least partial recur despit guidanc rang
low hang fruit margin expans larg end view though see
attract net margin profil rang sustain harvest medic cost
structur admin save opportun highlight jan competitor confer
off-set deliber pressur design grow hix marketplac start-up cost
geograph in-market market expans neg trend yield spread medicaid
model growth top line across mid-singl digit ss growth medicaid growth
hix modest opportun medicare/du ep goe
potenti bull case new contract tx region expand
anticip june contract award balanc sheet strong debt cap ratio
parent cash mn debt pay day claim payabl day
next big catalyst report expect rais may nyc
day expect color path growth across top line margin balanc sheet
huge ep beat margin tax rate consensu revenu
huge ep beat across board margin metric sg ratio tax rate
servic revenu ratio also beat beat particularli pronounc fl il tx
miss nm wa day claim payabl flat qoq day yoy
post huge beat street estim
qsum earn molina healthcar earn report svb leerink estim streetaccount estim report chang sequenti report chang yoy total revenu adj net incom mm dilut ep adjust ep na na average share corpor interest expens consensu estim revenu adj net incom ep qsum metric molina healthcar metric report svb leerink estim streetaccount estim report chang sequenti report chang yoy metric consolid bp bp servic revenu ratio na bp bp total revenu bp bp tax rate na bp day claim payabl cfo/net incom sourc compani report street account consensu svb leerink llc research estim molina healthcar inc
dcp day yoy day
claim payabl molina care membership report svb leerink estim streetaccount estim report chang sequenti report chang yoy enrol abd medicaid dual mmp medicar advantag tanf chip medicaid expans marketplac medicaid expans exchang enrol total molina healthcar inc
initi guid beat street prior ep includ prior year
develop miss revenu ep guidanc rang also higher
consensu though revenu guidanc miss street view ep
outlook larg aid tax rate project street
initi guidanc rang
parametercompani guidanc leerink estimatesconsensu estimatespremium revenu fee reimburs tax revenu revenu incom revenu cost cost expens tax expens insur fee amort interest expens tax tax incom net incom share outstand molina healthcar inc
hix marketplac perform guidanc surpris downsid hix membership
guidanc end manag see revenu
contract like revers margin compress
today high singl digit drive membership gain expect hix top line growth
like suffici off-set margin compress
hix marketplac perform guidanc surpris downsid
rais ep magnitud guidanc also includ recur
prior year develop compar see top line growth
flattish margin even ss growth offer mid-singl digit growth growth
hix repres balanc ep goe potenti bull case
new contract tx region expand anticip june
contract award rais ep
revenu overal expect premium revenu come approxim billion adecreas approxim due contract loss florida new mexico membershipattrit result conserv approach taken marketplac price joseph zubretski presid ceo director inc callw go go specif state-by-st michael mention texa roughli membership see declin wherer main driver membership declin know reenter somenew state former state exit utah wisconsin see level membership noth signific remain market fluctuat gain lost iment florida gain membership market fairli stabl exampl state ofcalifornia fairli stabl overal declin definit end januari right somewherearound tran cfo inc molina healthcar inc
rais ep respect
growth opportun beyond
revenu estim contempl expect success tx re-procur
consensussvb leerinksvb leerink oldconsensussvb leerinksvb leerink oldconsensussvb leerinksvb leerink oldrevenu net incom growth earli read give growth beyond would medicaid medicar ind-snp plan file notic intent play addit counti d-snp alon two state whichwould brand new ohio south carolina respect medicaid billion opportun come market estim thenext three year wave one louisiana minnesota hawaii kentucki possibl pennsylvania wave two tennesse west virginia indiana joseph zubretski presid ceo director inc call membership estim market shareestim revenu mm award dateeffect datetx molina healthcar inc
balanc sheet strong mm unregul parent cash ratio
debt cap potenti rate upgrad
debt capit remain end
polici downsid headlin could creat volatil view
close half earn stream across medicaid expans hix tx
lawsuit decis walk back scotu given american enjoy coverag
entitl fifth circuit court appeal conserv southern court
like hear case juli
rais pt
rais pt modestli pt base price-to-earnings averag
ep see price-to-earnings potenti expand pend court hear
may day potenti offer confid investor top line growth
stori margin preserv
capit molina healthcar inc
trade conserv consensu ep estim
except per oper tax contract oper incom continu net incom net growth revenu exclud molina healthcar inc
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
pt contempl price-to-earnings averag ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base absolut price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
price target base price-to-earnings averag ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
integr regulatori risk across merg ci esrx
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price target base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
pt contempl price-to-earnings consensu ep
price-to-earnings ep expect synergi across administr effici
retail steerag aet member benefit design chang floor rebat reduct
store base distribut part polici drive upsid estim also
multipl expans pt
underwrit risk aet asset trade peak margin commerci fulli
insur though medacorp commerci broker price survey give us confid
price environ remain appropri hard offer flat even potenti
modestli expand underwrit margin risk potenti futur margin compress
aet health insur even meaning given associ neg impact
debt ebitda load compani need focus debt
pay next month departur shawn guertin aet cfo
slate becom cfo make us less confid price postur
health insur book commenc new bulk compet
share gain commerci medicar advantag market
macroeconom risk risk macroeconom downturn higher
defens pbm sub sector given cyclic correl retail front store
sale employ data
regulatori risk convinc pbm add valu earn
low probabl threat potenti drug manufactur rebat elimin off-set
new busi model includ administr fee and/or perform guarante
expos pbm retail pharmaci busi compar
player pbm risk
execut integr risk face greater risk well given integr
pbm broader organ also transform agenda around
build retail front model amid risk leverag balanc sheet
e-commerce/amzn greater exposur eros sale on-line
channel well given exposur retail front store retail pharmaci e-
commerc though larg price retail multipl expect less like
pursu agenda becom pbm given associ integr clinic evid
base treatment guidelin integr provid network domin captiv pbm
model mega deal
remain posit reiter op rate month pt
contempl price-to-earnings averag ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings averag ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
averag cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
averag ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
